BBIO Institutional Ownership & Shareholders

BRIDGEBIO PHARMA INC (BBIO) is currently held by 464 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $13.47B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

Kohlberg Kravis Roberts & Co. L.P. is currently the largest disclosed institutional shareholder of BBIO tracked by InsiderSet, reporting ownership valued at approximately $987.68M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $993.91M, representing an estimated gain of +0.63% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 45% of the total disclosed BBIO value among the investors covered in this analysis. Major shareholders include Kohlberg Kravis Roberts & Co. L.P., Janus Henderson Group Plc, Blackrock, Inc., and several other long-term asset managers with concentrated positions in BRIDGEBIO PHARMA INC (BBIO).

This page ranks the largest institutional BBIO shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

464

Total Reported Value

$13.47B

Largest Holder

Kohlberg Kravis Roberts & Co. L.P.

Largest Position

$987.68M

Insider Transactions (90d)

16

Latest Filing Quarter

Q2 2026

New Institutional Positions

62

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Kohlberg Kravis Roberts & Co. L.P.17.30%13,260,971$987,677,120$993,909,776+$6,232,656+0.63%
Janus Henderson Group Plc0.49%13,179,013$978,607,712$987,767,024+$9,159,312+0.94%
Blackrock, Inc.0.01%10,287,156$766,187,363$771,022,342+$4,834,979+0.63%
Viking Global InvestorsOle Andreas Halvorsen2.11%9,949,219$741,017,831$745,693,964+$4,676,133+0.63%
Vanguard Capital Management Llc0.01%7,898,973$588,315,509$592,028,026+$3,712,517+0.63%
Vanguard Portfolio Management Llc0.03%7,656,722$570,272,655$573,871,314+$3,598,659+0.63%
Wellington Management Group Llp0.07%5,308,924$395,408,660$397,903,854+$2,495,194+0.63%
Two Sigma Investments, Lp0.26%4,722,185$351,708,339$353,927,766+$2,219,427+0.63%
Aisling Capital Management Lp72.48%4,589,611$341,834,227$343,991,344+$2,157,117+0.63%
State Street Corp0.01%4,435,932$330,388,215$332,473,103+$2,084,888+0.63%
Citadel Advisors Llc0.16%3,760,028$280,046,885$281,814,099+$1,767,214+0.63%
Invesco Ltd.0.02%3,700,934$275,645,564$277,385,003+$1,739,439+0.63%
D. E. Shaw & Co., Inc.0.17%3,633,007$270,586,362$272,293,875+$1,707,513+0.63%
Geode Capital Management, Llc0.01%3,418,419$254,669,075$256,210,504+$1,541,429+0.61%
Jane Street Group, Llc0.14%2,934,193$218,538,695$219,917,765+$1,379,070+0.63%
Banque Cantonale Vaudoise0.03%2,500$186,000,000$187,375-$185,812,625-99.90%
Jpmorgan Chase & Co0.01%2,397,995$173,229,954$179,729,725+$6,499,771+3.75%
Adage Capital Partners Gp, L.L.C.0.24%2,252,000$167,728,960$168,787,400+$1,058,440+0.63%
Polar Capital Holdings Plc0.44%2,063,609$153,697,598$154,667,495+$969,897+0.63%
Fmr Llc0.01%2,061,307$153,526,176$154,494,960+$968,784+0.63%
Manufacturers Life Insurance Company, The0.11%1,955,733$145,662,994$146,582,188+$919,194+0.63%
Sc Us (Ttgp), Ltd.0.43%1,860,364$138,559,911$139,434,282+$874,371+0.63%
Goldman Sachs Group Inc0.01%1,814,657$135,155,654$136,008,542+$852,888+0.63%
Ubs Group Ag0.02%1,757,152$130,872,681$131,698,542+$825,861+0.63%
Price T Rowe Associates Inc0.01%1,726,383$128,582,000$129,392,406+$810,406+0.63%
Charles Schwab Investment Management Inc0.02%1,709,417$127,317,378$128,120,804+$803,426+0.63%
Norges Bank0.01%1,693,773$126,152,213$126,948,286+$796,073+0.63%
Morgan Stanley0.01%1,693,652$126,143,276$126,939,217+$795,941+0.63%
Ameriprise Financial Inc0.02%1,551,663$115,568,042$116,297,142+$729,100+0.63%
Frazier Life Sciences Management, L.P.2.51%1,548,139$115,305,393$116,033,018+$727,625+0.63%
Point72 Asset Management, L.P.0.17%1,525,782$113,640,243$114,357,361+$717,118+0.63%
Alliancebernstein L.P.0.04%1,453,504$107,937,207$108,940,125+$1,002,918+0.93%
Pictet Asset Management Holding Sa0.10%1,448,126$107,362,071$108,537,044+$1,174,973+1.09%
Frontier Capital Management Co Llc0.95%1,373,057$102,265,291$102,910,622+$645,331+0.63%
Hood River Capital Management Llc0.73%1,347,535$100,364,407$100,997,748+$633,341+0.63%
Bank Of America Corp0.01%1,235,380$92,011,099$92,591,731+$580,632+0.63%
Balyasny Asset Management L.P.0.17%1,230,052$91,614,273$92,192,397+$578,124+0.63%
Squarepoint Ops Llc0.17%1,191,732$88,760,199$89,320,313+$560,114+0.63%
Bellevue Group Ag1.86%1,189,506$88,594,406$89,153,475+$559,069+0.63%
Bnp Paribas Financial Markets0.04%1,155,442$86,057,320$86,600,378+$543,058+0.63%
Laurion Capital Management Lp6.42%1,288,169$84,761,520$96,548,267+$11,786,747+13.91%
Gw&K Investment Management, Llc0.65%1,125,131$83,800,000$84,328,568+$528,568+0.63%
Vanguard Fiduciary Trust Co0.02%1,116,989$83,193,341$83,718,326+$524,985+0.63%
Hrt Financial Lp0.15%1,089,376$81,136,000$81,648,731+$512,731+0.63%
Primecap Management Co/Ca/0.04%1,015,980$75,670,190$76,147,701+$477,511+0.63%
Fil Ltd0.05%1,002,260$74,648,325$75,119,387+$471,062+0.63%
Clearbridge Investments, Llc0.06%993,103$73,966,324$74,433,070+$466,746+0.63%
Northern Trust Corp0.01%959,513$71,464,528$71,915,499+$450,971+0.63%
Citigroup Inc0.03%864,101$64,358,242$64,764,370+$406,128+0.63%
Renaissance Technologies LLCJim Simons0.09%856,846$63,817,890$64,220,608+$402,718+0.63%
Showing 50 of 464

Frequently asked questions about BBIO

  • Who are the largest institutional holders of BBIO?

    The largest institutional holders of BBIO reported in the latest SEC Form 13F filings include Kohlberg Kravis Roberts & Co. L.P., Janus Henderson Group Plc, Blackrock, Inc., Viking Global Investors, and Vanguard Capital Management Llc. InsiderSet ranks institutional holders by their latest reported BBIO position.

  • What is BBIO institutional ownership?

    This page tracks BBIO positions reported by institutional investment managers through SEC Form 13F. BRIDGEBIO PHARMA INC (BBIO) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own BBIO?

    InsiderSet currently tracks 464 institutional managers reporting BBIO holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of BBIO shareholders.

  • How much BBIO stock do institutions own?

    Institutional investment managers disclosed approximately $13.47B in BBIO holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was BBIO institutional ownership last updated?

    The latest BBIO institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional BBIO holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its BBIO position after the reporting date.

  • Are institutions buying or selling BBIO?

    Institutional buying and selling can be analyzed by comparing BBIO positions across consecutive 13F reporting periods. InsiderSet's BBIO Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View BBIO ownership changes.

  • How has BBIO institutional ownership changed over time?

    InsiderSet tracks BBIO institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.